Clinical Trials
7 trialsNCT01840488 2019-11-22
BN83495 Phase I in Post-menopausal Women
Ipsen
Phase 1 Completed
NCT00910091 2019-01-30
The Study of Oral Steroid Sulphatase Inhibitor BN83495 Versus Megestrol Acetate (MA) in Women With Advanced or Recurrent Endometrial Cancer
Ipsen
Phase 2 Completed
NCT00790374 2019-01-15
STX64PC
Ipsen
Phase 1 Completed
NCT01251354 2019-01-14
Study of BN83495 in Post-menopausal Women With Endometrial Cancer Post-chemotherapy
Ipsen
Phase 2 Terminated
NCT01230970 2019-01-07
Exploratory Study to Assess the Short Term Intratumoural and Peripheral Effects of BN83495 in Postmenopausal Women With Newly Diagnosed Breast Cancer
Ipsen
Phase 2 Terminated
NCT01662726 2016-03-14
IPET
Imperial College London
Phase 2 Terminated
NCT01785992 2015-03-24
IRIS
Imperial College London
Phase 2 Completed